Quadrant Capital Group’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
VCM
CCM
CAM
GCM
VPM
Quadrant Capital Group's LMAT Position: Q1 2026 in Review
Quadrant Capital Group increased its LeMaitre Vascular (LMAT) stake by 10% in Q1 2026, buying an estimated $39.1K and bringing the position to 4,345 shares worth $474K. The position accounts for 0.01% of the portfolio, ranked #923.
Quadrant Capital Group first reported a position in LMAT in Q1 2020 and has held it in 25 quarters since. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.
- Quadrant Capital Group held 4,345 shares of LeMaitre Vascular worth $474K as of Q1 2026.
- Quadrant Capital Group bought 410 LeMaitre Vascular shares in Q1 2026, an estimated $39.1K.
- LeMaitre Vascular made up 0.01% of Quadrant Capital Group's portfolio in Q1 2026, its #923 holding.
- Quadrant Capital Group first reported a position in LeMaitre Vascular in Q1 2020 and has held it in 25 quarters since.
- 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.
Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.